⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| N-Methylhistamine SCHEMBL27340947 | 1.00 | — | — | |
| N-Methylhistamine SCHEMBL19951025 | 0.98 | HRH4 (0.96) | — | |
| N-Methylhistamine SCHEMBL2183879 | 0.98 | TDP1 (1.00) | — | |
| N-Methylhistamine SCHEMBL1320841 | 0.98 | TDP1 (1.00) | — | |
| SCHEMBL14416066 | 0.88 | CYP2C9 (0.78) | — | |
| N-Methylhistamine SCHEMBL25277752 | 0.83 | CYP2C9 (0.70) | — | |
| N-Methylhistamine SCHEMBL20359327 | 0.82 | HRH4 (0.68) | — | |
| SCHEMBL246132 | 0.82 | — | — | |
| Hydrochloric Acid SCHEMBL17835480 | 0.80 | — | — | |
| SCHEMBL8288760 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1014 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12584924-B2 | Compositions and methods for diagnosing and treating chronic kidney disease | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2026-03-24 | — | — | US | claimed |
| US-20260076944-A1 | COMPOSITIONS AND METHODS FOR PROMOTING BRAIN HEALTH | UNIV CALIFORNIA (US) | 2026-03-19 | — | — | US | claimed |
| EP-4695602-A1 | METHODS OF DETECTING OVER-IMMUNOSUPPRESSION AND UNDER- IMMUNOSUPPRESSION IN RENAL TRANSPLANT RECIPIENTS | Olaris, Inc. (US) | 2026-02-18 | — | — | EP | claimed |
| WO-2025085668-A9 | METHODS OF DETECTING OVER-IMMUNOSUPPRESSION AND UNDER- IMMUNOSUPPRESSION IN RENAL TRANSPLANT RECIPIENTS | Olaris, Inc. (US) | 2025-07-17 | — | — | WO | claimed |
| WO-2025085668-A1 | METHODS OF DETECTING OVER-IMMUNOSUPPRESSION AND UNDER- IMMUNOSUPPRESSION IN RENAL TRANSPLANT RECIPIENTS | Olaris, Inc. (US) | 2025-04-24 | — | — | WO | claimed |
| EP-4457513-A1 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CHRONIC KIDNEY DISEASE | Société des Produits Nestlé S.A. (CH) | 2024-11-06 | — | — | EP | claimed |
| US-20240277668-A1 | HISTAMINE RECEPTOR AGONISTS FOR CANCER THERAPY IN CANCER PATIENTS UNRESPONSIVE TO CANCER IMMUNOTHERAPY AND WITH ELEVATED MYELOID DERIVED SUPPRESSOR CELLS | TSP THERAPEUTICS INC. | 2024-08-22 | — | — | US | claimed |
| CN-118435054-A | Compositions and methods for diagnosing and treating chronic kidney disease | 雀巢产品有限公司 | 2024-08-02 | — | — | CN | claimed |
| EP-4376835-A1 | HISTAMINE RECEPTOR AGONISTS FOR CANCER THERAPY IN CANCER PATIENTS UNRESPONSIVE TO CANCER IMMUNOTHERAPY AND WITH ELEVATED MYELOID DERIVED SUPPRESSOR CELLS | TSP Therapeutics Inc. (US) | 2024-06-05 | — | — | EP | claimed |
| US-20240165082-A1 | ORALLY ADMINISTERED COMPOSITIONS FOR CANCER TREATMENT | TSP THERAPEUTICS INC. | 2024-05-23 | — | — | US | claimed |
| EP-0946744-B1 | NOVEL POLYMERIC COMPLEXES FOR THE TRANSFECTION OF NUCLEIC ACIDS, WITH RESIDUES CAUSING THE DESTABILISATION OF CELL MEMBRANES | IDM IMMUNO DESIGNED MOLECULES (FR) | 2004-08-18 | — | — | EP | claimed |
| EP-1135481-B1 | NEW OLIGOMERIC CONJUGATES LIABLE TO TRANSFER BIOLOGICAL MOLECULES INTO CELLS | IDM IMMUNO DESIGNED MOLECULES (FR) | 2004-02-25 | — | — | EP | claimed |
| US-20030113309-A1 | Method for treatment of neurodegenerative diseases and effects of aging | EAD, LLC. | 2003-06-19 | — | — | US | claimed |
| US-20030082238-A1 | Matrices for drug delivery and methods for making and using the same | BABICH JOHN W (US) | 2003-05-01 | — | — | US | claimed |
| EP-1277477-A2 | Treatment of neurodegenerative diseases and the effects of aging | Delack, Elaine A. (US) | 2003-01-22 | — | — | EP | claimed |
| US-6395299-B1 | PARKINSON'S DISEASE | BIOSTREAM, INC. | 2002-05-28 | — | — | US | claimed |
| WO-2000047236-A1 | MATRICES FOR DRUG DELIVERY AND METHODS FOR MAKING AND USING THE SAME | BIOSTREAM, INC. (US) | 2000-08-17 | — | — | WO | claimed |
| EP-0214058-B1 | PHARMACEUTICAL COMPOSITION CONTAINING HISTAMINE DERIVATIVES | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 1992-05-06 | — | — | EP | claimed |
| EP-0209586-A1 | ANTI-HISTAMINE ANTIBODY PREPARATION WITH SPECIFICITY FOR A 4-(2-AMINOETHYL)IMIDAZOLYL GROUP ATTACHED DIRECTLY TO AN ALKYLENE CHAIN AND IMMUNOASSAY METHOD EMPLOYING THE PREPARATION. | PHARMACIA AB (SE) | 1987-01-28 | — | — | EP | claimed |
| WO-1986004420-A1 | ANTIBODY PREPARATION WITH SPECIFICITY FOR ALIPHATICALLY BOUND 4-(2-AMINOETHYL)IMIDAZOLYL GROUP, MANUFACTURE AND USE OF THE ANTIBODY PREPARATION | PHARMACIA AB (SE) | 1986-07-31 | — | — | WO | claimed |